A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer-Reference-Cited by-同舟云学术

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

Published:2018-01-05 Issue:3 Volume:48 Page:242-247
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Chen Tom Wei-Wu¹²³^ORCID,Yeh Dah-Cherng⁴,Chao Tsu-Yi⁵,Lin Ching-Hung¹⁶,Chow Louis Wing-Cheong⁷⁸,Chang Dwan-Ying¹²,Hsieh Yao-Yu⁵,Huang Shu-Min¹,Cheng Ann-Lii¹²⁶,Lu Yen-Shen¹²⁶,Consortium Taiwan Breast Cancer

Affiliation:

1. Department of Oncology and Internal Medicine, National Taiwan University Hospital

2. National Taiwan University Cancer Center

3. Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei

4. Breast Medical Center, Taichung Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation, Taichung

5. Division of Hematology and Oncology, Taipei Medical University-Shuang Ho Hospital, Taipei

6. Internal Medicine, National Taiwan University Hospital

7. Comprehensive Centre for Breast Diseases, UNIMED Medical Institute

8. Macau University of Science and Technology, Hong Kong

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/3/242/25535569/hyx188.pdf

Reference24 articles.

1. Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis;Shen;Cancer Epidemiol Biomarkers Prev,2005

2. Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia;Lin;Cancer Epidemiol Biomarkers Prev,2009

3. The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: a comparative study of the efficacy of anthracyclines and non-anthracyclines;Chen;Breast,2013

4. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Eng J Med,2012

5. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline;Giordano;J Clin Oncol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vinca Alkaloids as Chemotherapeutic Agents Against Breast Cancer;Discovery and Development of Anti-Breast Cancer Agents from Natural Products;2021

2. Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study;Anticancer Research;2020-07

3. A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer;Anticancer Research;2019-07

4. Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens;Clinical and Translational Oncology;2018-10-06